Indegene Ltd. logo

Indegene Ltd. (INDGN)

Market Closed
8 Dec, 10:00
XNSE XNSE
525. 60
-8
-1.5%
134.86B Market Cap
- P/E Ratio
0% Div Yield
319,717 Volume
- Eps
533.6
Previous Close
Day Range
520 537.6
Year Range
499 681.7
Want to track INDGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

INDGN closed today lower at ₹525.6, a decrease of 1.5% from yesterday's close, completing a monthly increase of 0% or ₹525.6. Over the past 12 months, INDGN stock gained 0%.
INDGN is not paying dividends to its shareholders.
The last earnings report, released on Jul 31, 2025, missed the consensus estimates by -0.03%. On average, the company has fell short of earnings expectations by -0.01%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XNSE (INR).

INDGN Chart

Similar

Anand Rathi Wealth Ltd.
2,839.5
-2.02%
Aptus Value Housing Finance India Ltd.
278.75
-1.05%
Karur Vysya Bank Ltd.
242.3
-2.36%
Jammu and Kashmir Bank Ltd.
100.05
-3.01%
CUB
City Union Bank Ltd.
264.9
-2.56%

Indegene Ltd. (INDGN) FAQ

What is the stock price today?

The current price is ₹525.60.

On which exchange is it traded?

Indegene Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is INDGN.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 134.86B.

Has Indegene Ltd. ever had a stock split?

No, there has never been a stock split.

Indegene Ltd. Profile

Insurance Industry
Financials Sector
Mr. Manish Gupta BTech, MBA CEO
XNSE Exchange
INE065X01017 ISIN
India Country
4,367 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Indegene Limited is a life sciences commercialization company with a global presence, headquartered in Bengaluru, India. Since its inception in 1998, Indegene has expanded its operations across the United States, Europe, and other international markets. The company focuses on serving biopharmaceutical, emerging biotech, and medical device companies through a multifaceted approach that encompasses both commercialization and technological solutions. Indegene operates across three main segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, and Omnichannel Activation & Others. Its offerings are designed to meet the diverse needs of the life science and healthcare industries, including regulatory compliance, medical education, and patient engagement strategies.

Products and Services

  • Enterprise Medical Solutions

    Indegene provides a suite of solutions aimed at enhancing the medical aspects of life sciences companies. These solutions help in the development of complex biotech and medical devices by offering support in areas such as medical education, regulatory compliance, and evidence generation.

  • Enterprise Commercial Solutions

    This segment offers services designed to improve the commercial success of life sciences organizations. Indegene's commercial solutions encompass strategies for market access, brand promotion, and customer engagement, leveraging analytics and technology to optimize market performance.

  • Omnichannel Activation & Others

    Indegene's Omnichannel Activation solutions focus on creating integrated, personalized customer experiences across multiple channels. This approach ensures cohesive messaging and greater engagement, crucial for today’s digital-first healthcare landscape. The "Others" in this segment include a variety of additional support services tailored to the specific needs of the industry.

  • NEXT Technology Platforms

    The company operates NEXT technology platforms, which represent Indegene's commitment to integrating advanced technology solutions such as data analytics, artificial intelligence (AI), and machine learning (ML) within the life sciences sector. These platforms are designed to streamline operations, enhance decision-making, and foster innovation for Indegene's clients.

  • Analytics, Technology, Commercial, Medical, Regulatory, and Safety Services

    Indegene offers comprehensive services spanning analytics, technology implementation, commercial optimization, medical education, regulatory compliance, and pharmacovigilance. These services are integral to addressing the complex challenges faced by life science and healthcare organizations, ensuring they can deliver on their commitment to patient care and product innovation.

Contact Information

Address: Manyata Embassy Business Park
Phone: 91 80 4674 4567